statistiche ricercatore

AMADORI, SERGIO

Distribuzione geografica

Continente	#
NA - Nord America	2.929
EU - Europa	2.635
AS - Asia	678
AF - Africa	103
SA - Sud America	63
OC - Oceania	34
Continente sconosciuto - Info sul continente non disponibili	12
Totale	6.454

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.855
DE - Germania	1.813
CN - Cina	234
GB - Regno Unito	202
IT - Italia	162
IN - India	97
FR - Francia	94
NL - Olanda	90
KR - Corea	83
CA - Canada	58
EG - Egitto	44
ID - Indonesia	39
IE - Irlanda	37
JP - Giappone	34
SE - Svezia	32
UA - Ucraina	32
ZA - Sudafrica	32
BR - Brasile	31
RU - Federazione Russa	31
AU - Australia	30
VN - Vietnam	27
IR - Iran	21
CZ - Repubblica Ceca	18
HK - Hong Kong	16
IQ - Iraq	16
PK - Pakistan	16
MX - Messico	14
SG - Singapore	14
RO - Romania	13
TR - Turchia	13
ES - Italia	12
PE - Perù	12
GR - Grecia	11
IL - Israele	10
FI - Finlandia	9
NO - Norvegia	9
AE - Emirati Arabi Uniti	8
CL - Cile	8
EU - Europa	8
NG - Nigeria	8
PT - Portogallo	8
TH - Thailandia	8
AT - Austria	7
BE - Belgio	6
CH - Svizzera	6
HR - Croazia	6
HU - Ungheria	6
MY - Malesia	6
PH - Filippine	6
PL - Polonia	6
SA - Arabia Saudita	6
TW - Taiwan	6
AR - Argentina	5
BY - Bielorussia	5
CO - Colombia	5
LT - Lituania	5
LY - Libia	5
AP - ???statistics.table.value.countryCode.AP???	4
DK - Danimarca	4
JO - Giordania	4
BG - Bulgaria	3
ET - Etiopia	3
KE - Kenya	3
CY - Cipro	2
DZ - Algeria	2
NZ - Nuova Zelanda	2
OM - Oman	2
PG - Papua Nuova Guinea	2
RS - Serbia	2
AL - Albania	1
EC - Ecuador	1
EE - Estonia	1
HN - Honduras	1
IS - Islanda	1
KG - Kirghizistan	1
KW - Kuwait	1
LB - Libano	1
LK - Sri Lanka	1
MA - Marocco	1
MK - Macedonia	1
ML - Mali	1
MM - Myanmar	1
MU - Mauritius	1
NP - Nepal	1
PS - Palestinian Territory	1
SD - Sudan	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TN - Tunisia	1
UZ - Uzbekistan	1
VE - Venezuela	1
YE - Yemen	1
ZW - Zimbabwe	1
Totale	6.454

Salva come PNG Salva come JPEG

Città	#
Woodbridge	548
Houston	407
Fairfield	202
Nürnberg	139
Ann Arbor	137
Wilmington	131
Buffalo	115
Ashburn	108
Seattle	106
Santa Cruz	97
Cambridge	64
Beijing	47
Rome	39
University Park	39
Guangzhou	33
Leawood	32
Muizenberg	28
Dublin	27
Shanghai	27
Chicago	26
Mountain View	25
Seongnam	24
Stockholm	20
Hangzhou	19
Henderson	18
Phoenix	18
Jakarta	16
Los Angeles	16
Tokyo	16
Boardman	15
Ottawa	15
Delhi	14
Dong Ket	14
San Francisco	14
Dexheim	13
Zhengzhou	13
London	12
San Diego	12
Wuhan	12
Bengaluru	11
Manchester	11
Paris	11
Kumar	10
Las Vegas	10
Philadelphia	10
Riva	10
Amsterdam	9
Clearwater	9
Helsinki	9
Lima	9
Seoul	9
Toronto	9
Florence	8
New York	8
Columbus	7
Durham	7
Islamabad	7
Atlanta	6
Central	6
Fremont	6
Hanoi	6
Ho Chi Minh City	6
Lake Forest	6
Newcastle upon Tyne	6
Pietra Ligure	6
Rochester	6
Scranton	6
Tong	6
Central District	5
Changsha	5
Chengdu	5
Gurgaon	5
Mexico	5
Milan	5
Minneapolis	5
Montréal	5
Nanjing	5
Portland	5
San Jose	5
Ankara	4
Athens	4
Atherstone	4
Batu Pahat	4
Birmingham	4
Bucharest	4
Cairo	4
Concorezzo	4
Council Bluffs	4
Denver	4
Easton	4
Edwardsville	4
Fortaleza	4
Jinan	4
Madison	4
Montreal	4
Mumbai	4
Oslo	4
Pasadena	4
Perugia	4
Salt Lake City	4
Totale	3.027

Salva come PNG Salva come JPEG

Nome	#
Effect of a p210 multipeptide vaccine associated with imatinib or interferon in patients with chronic myeloid leukaemia and persistent residual disease: a multicentre observational trial., file e291c0d4-5305-cddb-e053-3a05fe0aa144	1.005
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia, file e291c0d4-3ea6-cddb-e053-3a05fe0aa144	927
Pyrrolo[1,2-b][1,2,5]benzothiadiazepines (PBTDs): A new class of agents with high apoptotic activity in chronic myelogenous leukemia K562 cells and in cells from patients at onset and who were imatinib-resistant, file e291c0d4-5227-cddb-e053-3a05fe0aa144	783
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia., file e291c0d4-55a8-cddb-e053-3a05fe0aa144	723
Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management., file e291c0d4-3eab-cddb-e053-3a05fe0aa144	570
Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA groups study AML-10, file e291c0d4-55ac-cddb-e053-3a05fe0aa144	501
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemias, file e291c0d3-f756-cddb-e053-3a05fe0aa144	458
Prognostic impact of genetic characterization in the GIMEMA LAM99P multicenter study for newly diagnosed acute myeloid leukemia, file e291c0d4-40af-cddb-e053-3a05fe0aa144	380
PYRROLO[1,2-b][1,2,5]BENZOTHIADIAZEPINES (PBTDs) induce apoptosis in K562 cells., file e291c0d4-5228-cddb-e053-3a05fe0aa144	312
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia, file e291c0d6-4003-cddb-e053-3a05fe0aa144	268
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high risk acute myeloid leukemia., file e291c0d4-3f39-cddb-e053-3a05fe0aa144	233
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications, file e291c0d6-47b5-cddb-e053-3a05fe0aa144	179
Minimal residual disease detection in pediatric acute myeloid leukemia: does flow cytometry score a point over molecular biology?, file e291c0d4-7e94-cddb-e053-3a05fe0aa144	153
Low dose clofarabine in combination with a standard remission induction in patients 18-60 years with previously untreated intermediate and bad risk AML or high risk MDS:combined Phase I/II results of the EORTC/GIMEMA AML-14A Trial, file e291c0d6-76e2-cddb-e053-3a05fe0aa144	141
Fludarabine, Cytarabine and Gentuzumab Ozogamicin (FLA-GO) as Salvage Therapy and Bridge to Transplant in Adult Relapsed Acute Myeloid Leukemia (AML) Patients, file e291c0d8-1e39-cddb-e053-3a05fe0aa144	80
Recurrence of a t(8;21)-positive acute myeloid leukemia in the form of a granulocytic sarcoma involving cranial bones: a diagnostic and therapeutic challenge, file e291c0d4-7c44-cddb-e053-3a05fe0aa144	55
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol, file e291c0da-0cd4-cddb-e053-3a05fe0aa144	28
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long-term follow-up of the EORTC-GIMEMA randomized AML-10 trial, file 9a4bec45-1e1f-4ed9-8825-9da5732d44a5	3
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia, file 69e4e20a-517f-4b84-81d9-cfbd4c30dfe2	2
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia, file e291c0d6-cd8b-cddb-e053-3a05fe0aa144	2
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia, file e291c0d8-1b47-cddb-e053-3a05fe0aa144	2
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature, file e291c0d6-4000-cddb-e053-3a05fe0aa144	1
Impact of NPM1/FLT3-ITD genotypes defined by the2017 European LeukemiaNet in patients with acute myeloid leukemia, file e291c0d7-9e17-cddb-e053-3a05fe0aa144	1
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia, file e291c0d8-d450-cddb-e053-3a05fe0aa144	1
10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial, file ec052489-d206-4d36-916b-9dd9557bdf0b	1
Totale	6.809

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	9.710
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	9.710

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	333	0	0	0	0	0	0	0	0	0	0	166	167
2019/2020	1.189	119	140	105	118	88	99	76	87	120	87	88	62
2020/2021	840	66	90	50	66	93	52	73	74	54	88	68	66
2021/2022	869	65	48	58	145	123	43	41	40	65	59	120	62
2022/2023	627	42	45	115	85	51	86	57	27	37	28	31	23
2023/2024	319	36	28	40	33	42	26	32	49	21	12	0	0
Totale													6.809